Exploring pharmacological significance of chalcone scaffold: A review

Current Medicinal Chemistry

Volumn 19, Issue 2, 2012, Pages 209-225

  Sahu, N K ^a   Balbhadra, S S ^a   Choudhary, J ^a   Kohli, D V ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Anticancer activity; Antimalarial; Butein; Chalcone; Licochalcone; Xanthohumol; , unsaturated ketone

Indexed keywords

3 HYDROXYXANTHOANGELOL; 3 PRENYLISOLIQUIRITIGENIN; 4' METHYLXANTHOHUMOL; ALPHA TOCOPHEROL; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ANTIVIRUS AGENT; ASCORBIC ACID; BROUSSOCHALCONE A; BUTEIN; CARDAMONIN; CHALCONE; CHALCONE DERIVATIVE; DESMETHYLXANTHOHUMOL; FERULIC ACID; ISOLIQUIRITIGENIN; ISOSALIPURPOSIDE; ISOVBAVACHALCONE; LICOCHALCONE A; NARINGENIN; PARA COUMARIC ACID; PHLORETIN; RESVERATROL; STERCURENSIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; XANTHOANGELOL B; XANTHOHUMOL; XANTHOKEISMINS A;

ANTIBACTERIAL ACTIVITY; ANTIDIABETIC ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMALARIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROTOZOAL ACTIVITY; ANTIULCER ACTIVITY; ANTIVIRAL ACTIVITY; BLADDER CANCER; CYTOTOXICITY; DRUG BLOOD LEVEL; ENZYME INHIBITION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMODIUM FALCIPARUM; PROSTATE CANCER; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 84857587699     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712803414132     Document Type: Review

References (115)

1. Di Carlo, G.; Mascolo, N.; Izzo, A.A.; Capasso, F. Flavonoids: Old and new aspects of a class of natural therapeutic drugs. Life Sci., 1999, 65, 337-353. (Pubitemid 29325278)
2. Dhar, D.N. The Chemistry of Chalcones and Related Compounds, John Wiley: New York, 1981.
3. Ni, L.; Meng, C.Q.; Sikorski, J.A. Recent advances in therapeutic chalcones. Expert Opin. Ther. Pat., 2004, 14, 1669-1691. (Pubitemid 39625100)
4. Guida, A.; Lhouty, M. H.; Tichit, D.; Figueras, F.; Geneste, P. Hydrotalcites as base catalysts. Kinetics of Claisen-Schmidt condensation, intramolecular condensation of acetonylacetone and synthesis of chalcone. Appl. Catal. A, 1997, 164, 251-264. (Pubitemid 127396868)
5. Eddarir, S.; Cotelle, N.; Bakkour,Y.; Rolando, C. An efficient synthesis of chalcones based on the Suzuki reaction. Tetrahedron Lett., 2003, 44, 5359-5363. (Pubitemid 36724806)
6. Romanelli, G.; Pasquale, G.; Sathicq, A.; Thomas, H.; Autino, J.; Vázquez, P. Synthesis of chalcones catalyzed by aminopropylated silica sol-gel under solvent-free conditions. J. Mol. Catal. A: Chem., 2011, 340, 24-32.
7. Dimmock, J.R.; Elias, D.W.; Beazely, M.A.; Kandepu, N.M. Bioactivities of chalcones. Curr. Med. Chem., 1999, 6, 1125-1149.
8. Nowakowska, Z. A review of anti-infective and anti-inflammatory chalcones. Eur. J. Med. Chem., 2007, 42, 125-137. (Pubitemid 46282233)
9. Batovska, D.I.; Todorova, I.T. Trends in utilization of the pharmacological potential of chalcones. Curr. Clin. Pharmacol., 2010, 5, 1-29.
10. Morel, I.; Lescoat, G.; Cogrel, P.; Sergent, O.; Pasdeloup, N.; Brissot, P.; Cillard, P.; Cilliard, J. Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on iron-loaded rat hepatocyte cultures. Biochem. Pharmacol., 1993, 45, 13-19. (Pubitemid 23023735)
11. Dziedzic, S.Z.; Hudson, B.J.F. Polyhydroxy chalcones and flavanones as antioxidants for edible oils. Food Chem., 1983, 12, 205-212.
12. Cai, Y-Z., Sun, M.; Xing J.; Luo Q.; Corke H. Structure-activity scavenging activity relationship of phenolic compounds from traditional chinese medicinal plants. Life Sci., 2006, 78, 2872-2888.
13. Cheng, Z.J.; Lin, C.N.; Hwang, T.L.; Teng, C.M. Broussochalcone A, a potent antioxidant and effective suppressor of inducible nitric oxide synthase in lipopolysaccharide-activated macrophages. Biochem. Pharmacol., 2001, 61, 939-946.
14. Aoki, N.; Muk,o M.; Ohta, E.; Ohta, S. C-Geranylated chalcones from the stems of Angelica keiskei with superoxide-scavenging activity. J. Nat. Prod., 2008, 71, 1308-1310.
15. Rao, G.V.; Swamy, B.N.; Chandregowda, V.; Reddy, G.C. Synthesis of (±)Abyssinone I and related compounds: Their anti-oxidant and cytotoxic activities. Eur. J. Med. Chem., 2009, 44, 2239-2245.
16. Vogel, S.; Ohmayer, S.; Brunner, G.; Heilmann, J. Natural and nonnatural prenylated chalcones: Synthesis, cytotoxicity and antioxidative activity. Bioorg. Med. Chem., 2008, 16, 4286-4293. (Pubitemid 351539046)
17. Agnihotri, V.K.; ElSohly, N.H.; Khan, S.I.; Smillie, T.J.; Khan, I.A.; Walker, L.A. Antioxidant constituents of Nymphaea caerulea flowers. Phytochemistry, 2008, 69, 2061-2066.
18. Dinkova-Kostova, A.T.; Abeygunawardana, C.; Talalay, P. Chemoprotective properties of phenylpropenoids, bis(benzylidene)cycloalkanones, and related Michael reaction acceptors: Correlation of potencies as phase 2 enzyme inducers and radical scavengers. J. Med. Chem., 1998, 41, 5287-5296. (Pubitemid 29016320)
19. Modzelewska, A.; Pettit, C.; Achanta, G.; Davidson, N.E.; Huang, P.; Khana, S.R. Anticancer activities of novel chalcone and bis-chalcone derivatives. Bioorg. Med. Chem., 2006, 14, 3491-3495.
20. Mendes, V.; Monteiro, R.R.; Pestana, D.; Teixeira, D.; Calhau, C.A.O.; Azevedo, I. Xanthohumol influences preadipocyte differentiation: Implication of antiproliferative and apoptotic effects. J. Agric. Food Chem., 2008, 56, 11631-11637.
21. Yagura, T.; Motomiya, T.; Ito, M.; Honda, G.; Iida, A.; Kiuchi, F.; Tokuda, H.; Nishino, H. Anticarcinogenic compound in the Uzbek medicinal plant, Helichrysum maracandicum. J. Nat. Med., 2008, 62, 174-178.
22. Achanta, G.; Modzelewska, A.; Feng, L.; Khan, S.R.; Huang, P. A boronicchalcone derivative exhibits potent anticancer activity through inhibition of the proteasome. Mol. Pharmacol., 2006, 70, 426-433.
23. Simirgiotis, M.J.; Adachi, S.; To, S.; Yang, H.; Reynertson, K.A.; Basile, M.J.; Gil, R.R.; Weinstein, I.B.; Kennelly, E.J. Cytotoxic chalcones and antioxidants from the fruits of Syzygium samarangense (Wax Jambu). Food Chem., 2008, 107, 813-819. (Pubitemid 350116386)
24. Zhang, L.R.; Chen, W.; Li, X. A novel anticancer effect of butein: Inhibition of invasion through the ERK1/2 and NF-πB signaling pathways in bladder cancer cells. FEBS Lett., 2008, 582, 1821-1828.
25. Reddy, M.V.B.; Su, C.R.; Chiou, W.F.; Liu, Y.N.; Chen, R.Y.H.; Bastow, K.F.; Lee, K.H.; Wu, T.S. Design, synthesis, and biological evaluation of mannich bases of heterocyclic chalcone analogs as cytotoxic agents. Bioorg. Med. Chem., 2008, 16, 7358-7370.
26. Kerr, D.J.; Hamel, E.; Jung, M.K.; Flynn, B.L. The concise synthesis of chalcone, indanone and indenone analogues of combretastatin A4. Bioorg. Med. Chem., 2007, 15, 3290-3298. (Pubitemid 46505268)
27. Nishimura, R.; Tabata, K.; Arakawa, M.; Ito, Y., Kimura, Y., Akihisa, T., Nagai, H., Sakuma, A., Kohno, H., Suzuki, T. Isobavachalcone, a chalcone constituent of Angelica keiskei, induced apoptosis in neuroblastoma. Biol. Pharm. Bull., 2007, 30, 1878-1883. (Pubitemid 47607775)
28. Navarini, A.L.F.; Chiaradia, L.D.; Mascarello, A.; Fritzen, M.; José Nunes, R.; Yunes, R.A.; Creczynski-Pasa, T.B. Hydroxychalcones induce apoptosis in B16-F10 melanoma cells via GSH and ATP depletion. Eur. J. Med. Chem., 2009, 44, 1630-1637.
29. Romagnoli, R.; Baraldi, P.G.; Carrion, M.D.; Cruz-Lopez, O.; Cara, C.L.; Balzarini, J.; Hamel, E.; Canella, A.; Fabbri, E.; Gambari, R.; Basso, G.; Viola, G. Hybrid α-bromoacryloylamido chalcones. Design, synthesis and biological evaluation. Bioorg. Med. Chem. Lett., 2009, 19, 2022-2028.
30. Vogel, S.; Ohmayer, S.; Brunner, G.; Heilmann, J. Natural and non-natural prenylated chalcones: Synthesis, cytotoxicity and anti-oxidative activity. Bioorg. Med. Chem., 2008, 16, 4286-4293. (Pubitemid 351539046)
31. Thorburn, A.; Behbakht, K.; Ford, H. TRAIL receptor-targeted therapeutics: Resistance mechanisms and strategies to avoid them. Drug Resist. Updat. 2008, 11, 17-24.
32. Szliszka, E.; Czuba, Z.P.; Mazur, B.; Sedek, L.; Paradysz, A.; Krol, W. Chalcones enhance TRAIL-induced apoptosis in prostate cancer cells. Int. J. Mol. Sci., 2010, 11, 1-13.
33. Szliszka, E.; Czuba, Z.P.; Mazur, B.; Paradysz, A.; Krol, W. Chalcones and dihydrochalcones augment TRAIL-mediated apoptosis in prostate cancer cells. Molecules, 2010, 15, 5336-5353.
34. Bandgar, B.P.; Gawande, S.S.; Bodade, R.G.; Totre, J.V.; Khobragade, C.N. Synthesis and biological evaluation of simple methoxylated chalcones as anticancer, anti-inflammatory and antioxidant agents. Bioorg. Med. Chem., 2010, 18, 1364-1370.
35. Bandgar, B.P.; Gawande, S.S. Synthesis and biological screening of a combinatorial library of α-chlorovinyl chalcones as anticancer, antiinflammatory and antimicrobial agents. Bioorg. Med. Chem., 2010, 18, 2060-2065.
36. Sharma, A.; Chakravarti, B.; Gupt, M.P.; Siddiqui, J.A.; Konwar, R.; Tripathi, R.P. Synthesis and anti-breast cancer activity of biphenyl based chalcones. Bioorg. Med. Chem., 2010, 18, 4711-4720.
37. Kamal, A.; Ramakrishna, G.; Raju, P.; Viswanath, A.; Ramaiah, M.J.; Balakishan, G.; Bhadra, M.P. Synthesis and anti-cancer activity of chalcone linked imidazolones. Bioorg. Med. Chem. Lett., 2010, 20, 4865-4869.
38. Kumar, D.; Kumar, N.M.; Akamatsu, K.; Kusaka, E.; Harada, H.; Ito, T. Synthesis and biological evaluation of indolyl chalcones as antitumor agents. Bioorg. Med. Chem. Lett., 2010, 20, 3916-3919.
39. Sashidhara, K.V.; Kumara, A.; Kumar, M.; Sarkar, J.; Sinha, S. Synthesis and in vitro evaluation of novel coumarin-chalcone hybrids as potential anticancer agents. Bioorg. Med. Chem. Lett., 2010, 20, 7205-7211.
40. Zhang, H.J.; Qian, Y.; Zhu, D.D.; Yang, X.G.; Zhu, H.L. Synthesis, molecular modeling and biological evaluation of chalcone thiosemicarbazide derivatives as novel anticancer agents. Eur. J. Med. Chem., 2011, 46, 4702-4708.
41. Herencia, F.; Ferrandiz, M.L.; Ubeda, A.; Dominguez, J.N.; Charris, J.E.; Lobo, G.M.; Alcaraz, M.J.; Synthesis and anti-inflammatory activity of chalcone derivatives. Bioorg. Med. Chem. Lett., 1998, 8, 1169-1174. (Pubitemid 28231392)
42. Rojas, J.; Dominguez, J.N.; Charris, J.E.; Lobo, G.M.; Paya, M.; Ferrandiz, M.L. Synthesis and inhibitory activity of dimethylamino-chalcone derivatives on the induction of nitric oxide synthase. Eur. J. Med. Chem., 2002, 37, 699-705. (Pubitemid 34874903)
43. Nakamura, C.; Kawasaki, N.; Miyataka, H.; Jayachandran, E.; Kim, I.H.; Kirk, K.L.; Taguchi, T.; Takeuchi, Y.; Horie H.; Satoh, T. Synthesis and biological activities of fluorinated chalcone derivatives. Bioorg. Med. Chem., 2002, 10, 699-706. (Pubitemid 34112463)
44. Gacche, R.; Khsirsagar, M.; Kamble, S.; Bandgar, B.; Dhole, N.; Shisode, K.; Chaudhari, A. Antioxidant and anti-inflammatory related activities of selected synthetic chalcones: Structure-activity relationship studies using computational tools. Chem. Pharm. Bull., 2008, 56, 897-901. (Pubitemid 351949700)
45. Meng, C.Q.; Ni, L.; Worsencroft, K.J.; Ye, Z.; Weingarten, M.D.; Simpson, J.E.; Skudlarek, J.W.; Marino, E.M.; Suen, K.L.; Kunsch, C.; Souder, A.; Howard, R.B.; Sundell, C.L.; Wasserman, M.A.; Sikorski, J.A. Carboxylated, heteroaryl-substituted chalcones as inhibitors of vascular cell adhesion molecule-1 expression for use in chronic inflammatory diseases. J. Med. Chem., 2007, 50, 1304-1315. (Pubitemid 46496329)
46. Lee, S.H.; Sohn, D.H.; Jin, X.Y.; Kim, S.W.; Choi , S.C.; Seo, G.S. 2',4',6'-Tris(methoxymethoxy) chalcone protects against trinitrobenzene sulfonic acid-induced colitis and blocks tumor necrosis factor-β-induced intestinal epithelial inflammation via heme oxygenase 1-dependent and independent pathways. Biochem. Pharmacol., 2007, 74, 870-880. (Pubitemid 47212081)
47. Zarghi, A.; Zebardast, T.; Hakimion, F.; Shirazi, F.H.; Rao, PNP.; Knaus, E.E. Synthesis and biological evaluation of 1,3-diphenylprop-2-en-1-ones possessing a methanesulfonamido or an azido pharmacophore as cyclooxygenase-1/-2 inhibitors. Bioorg. Med. Chem., 2006, 14, 7044-7050. (Pubitemid 44307637)
48. Chiaradia, L.D.; Santos, R.; Vitor, C.E.; Vieira, A.A.; Leal, P.C.; Nunes, R.J.; Calixto, J.B.; Yunes, R.A. Synthesis and pharmacological activity of chalcones derived from 2,4,6-trimethoxyacetophenone in RAW 264.7 cells stimulated by LPS: Quantitative structure-activity relationships. Bioorg. Med. Chem., 2008, 16, 658-667. (Pubitemid 351163067)
49. Rao, Y.K.; Fang, S.H.; Tzeng, Y.M. Synthesis and biological evaluation of 3', 4',5'-trimethoxychalcone analogues as inhibitors of nitric oxide production and tumor cell proliferation. Bioorg. Med. Chem., 2009, 17, 7909-7914.
50. Yang, H-M.; Shin, H-R.; Cho, S-H.; Bang, S.C.; Song, G.Y.; Ju, J.H.; Kim, M.K.; Lee, S.H.; Ryu, J.C.; Kim, Y.; Jung, S.H. Structural requirement of chalcones for the inhibitory activity of interleukin-5. Bioorg. Med. Chem., 2007, 15, 104-111. (Pubitemid 44738590)
51. Kim, J-Y.; Park, S.J.; Yun, K-J.; Cho, Y-W.; Park, H-J.; Lee, K-T. Isoliquiritigenin isolated from the roots of Glycyrrhiza uralensis inhibits LPS-induced iNOS and COX-2 expression via the attenuation of NF-kB in RAW 264.7 macrophages. Eur. J. Pharmacol., 2008, 584, 175-184.
52. Reddy, N.P.; Aparoy, P.; Reddy, T.C.M.; Achari, C.; Sridhar, P.R.; Reddanna, P. Design, synthesis, and biological evaluation of prenylated chalcones as 5-LOX inhibitors. Bioorg. Med. Chem., 2010, 18, 5807-5815.
53. Sashidhara, K.V.; Kumar, M.; Modukuri, R.K.; Sonkar, R.; Bhatia, G.; Khanna, A.K.; Rai, S.; Shukla, R. Synthesis and anti-inflammatory activity of novel biscoumarin-chalcone hybrids. Bioorg. Med. Chem. Lett., 2011, 21, 4480-4484.
54. Haraguchi, H.; Tanimoto, K.; Yukiyoshi, T.; Mizutani, K.; Kinoshita, T. Antioxidative and superoxide scavenging activities of retrochalcones in Glycyrrhiza inflate. Phytochemistry, 1998, 48, 125-129.
55. Hatano, T.; Shintani, Y.; Aga, Y.; Shiota, S.; Tsuchiya, T.; Yoshida, T. Phenolic constituents of Licorice. VIII. Structures of glicophenone and Glicoisoflavanonem and effects of licorice phenolics on methicillin-resistant Staphylococcus aureus. Chem. Pharm. Bull., 2000, 48, 1286-1292.
56. Kromann, H.; Larsen, M.; Boesen, T.; Schønning, K.; Nielsen, S.F. Synthesis of prenylated benzaldehydes and their use in the synthesis of analogues of licochalcone A. Eur. J. Med. Chem., 2004, 39, 993-1000. (Pubitemid 39389110)
57. Joshi, A.S.; Li, X.C.; Nimrod, A.C.; ElSohly, H.N.; Walker, L.A.; Clark, A.M. Dihydrochalcones from Piper longicaudatum. Planta Med., 2001, 67, 186-188. (Pubitemid 32234693)
58. Nielsen, S.F.; Boesen, T.; Larsen, M.; Schønning K.; Kromann, H. Antibacterial chalcones-bioisosteric replacement of the 4'-hydroxy group. Bioorg. Med. Chem., 2004, 12, 3047-3054. (Pubitemid 38622138)
59. Nielsen, S.F.; Larsen, M.; Boesen, T.; Schønning, K.; Kromann, H. Cationic chalcone antibiotics. design, synthesis, and mechanism of action. J. Med. Chem., 2005, 48, 2667-2677. (Pubitemid 40516456)
60. Aponte, J.C.; Verastegui, M.; Malaga, E.; Zimic, M.; Quiliano, M.; Vaisberg, A.J.; Gilman, R.H.; Hammond, G.B. Synthesis, cytotoxicity, and antitrypanosoma cruzi activity of new chalcones. J. Med. Chem., 2008, 51, 6230-6234.
61. Selvakumar, N.; Kumar, G.S.; Azhagan, A.M.; Rajulu, G.G.; Sharma, S.; Kumar, M.S.; Das, J.; Iqbal, J.; Trehan, S. Synthesis, SAR and antibacterial studies on novel chalcone oxazolidinone hybrids. Eur. J. Med. Chem., 2007, 42, 538-543. (Pubitemid 46517786)
62. Tomar, V.; Bhattacharjee, G.; Kamaluddin, A.K. Synthesis and antimicrobial evaluation of new chalcones containing piperazine or 2,5-dichlorothiophene moiety. Bioorg. Med. Chem. Lett., 2007, 17, 5321-5324. (Pubitemid 47391290)
63. Liu, X.F.; Zheng, C.J.; Sun, L.P.; Liu, X.K.; Piao, H.R. Synthesis of new chalcone derivatives bearing 2,4-thiazolidinedione and benzoic acid moieties as potential anti-bacterial agents. Eur. J. Med. Chem., 2011, 46, 3469-3473.
64. Liaras, K.; Geronikaki, A.; Glamoclija, J.; Ciric, A.; Sokovic, M. Thiazolebased chalcones as potent antimicrobial agents. Synthesis and biological evaluation. Bioorg. Med. Chem., 2011, 19, 3135-3140.
65. Opletalová, V.; Sedivý, D. Chalcones and their heterocyclic analogs as potential antifungal chemotherapeutic agents. Ceska. Slov. Farm., 1999, 48, 252-255.
66. Boeck, P.; Leal, P.C.; Yunes, R.A.; Fiiho, V.C.; Lopez, S.; Sortino, M.; Escalante, A.; Furlan, R.L.E.; Zacchino, S. Antifungal activity and studies on mode of action of novel xanthoxyline-derived chalcones. Arch. Pharm. Chem. Life Sci., 2005, 338, 87-95. (Pubitemid 40592928)
67. ElSohly, H.N.; Joshi, A.S.; Nimrod, A.C.; Walker, L.A.; Clark, A.M. Antifungal chalcones from maclura tinctoria. Planta Med., 2001, 67, 87-89. (Pubitemid 32199955)
68. Lopez, S.N.; Castelli, M.V.; Zacchino, S.A.; Dominguez, J.N.; Lobo, G.; Jaime, C.C.; Cortes, J.C.G.; Ribas, J.C.; Devia, C.; Ana, M.R.; Ricardo, D.E. In vitro antifungal evaluation and structure-activity relationships of a new series of chalcone derivatives and synthetic analogues, with inhibitory properties against polymers of the fungal cell wall. Bioorg. Med. Chem., 2001, 9, 1999-2013. (Pubitemid 32739188)
69. Kaveri, M.V.; Prabhakaran, R.; Karvembu, R.; Natarajan, K. Synthesis and spectral studies of [RuCl(CO)(L)(PPh3)(B)](HL=2'-hydroxychalcones and B=PPh3, pyridine or piperidine) and their catalytic and biological applications. Spectrochim. Acta. Part A, 2005, 61, 2915-2918. (Pubitemid 41316032)
70. Cheenpracha, S.; Karalai, C.; Ponglimanont, C.; Subhadhirasakul, S.; Tewtrakul, S.; Anti-HIV-1 protease activity of compounds from Boesenbergia pandurata. Bioorg. Med. Chem., 2006, 14, 1710-1714. (Pubitemid 43199504)
71. Wu, J.H.; Wang, X.H.; Yi, Y.H.; Lee, K.H. Anti-AIDS agents 54, A potent anti-HIV chalcone and flavonoids from genus Desmos. Bioorg. Med. Chem. Lett., 2003, 13, 1813-1815.
72. Wang, Q.; Ding, Z.H.; Liu, J.K.; Zheng, Y.T. Xanthohumol, a novel anti-HIV-1 agent purified from Hop Humulus lupulus. Antiviral Res., 2004, 64, 189-194. (Pubitemid 39506839)
73. Deng, J.; Kelly, J.A.; Barchi, J.J.; Sanchez, T., Dayam, R., Pommier, Y., Neamati, N. Mining the NCI antiviral compounds for HIV-1 intergase inhibitors. Bioorg. Med. Chem., 2006, 14, 3785-3792.
74. Friis-Moller, A.; Chen, M.; Fuursted, K.; Christensen, S.B.; Kharazmi, A. In vitro antimycobacterial and antilegionella activity of licochalocne A from Chinese licorice roots. Planta Med., 2002, 68, 416-419. (Pubitemid 34606683)
75. Lin, Y.M.; Zhou, Y.; Flavin, M.T.; Zhou, L.M.; Nie, W.; Chen, F.C. Chalcones and flavonoids as anti-tuberculosis agents. Bioorg. Med. Chem., 2002, 10, 2795-2802. (Pubitemid 34626243)
76. Sivakumar, P.M.; Seenivasan, S.P.; Kumar V.; Doble, M. Synthesis, antimycobacterial activity evaluation, and QSAR studies of chalcone derivatives. Bioorg. Med. Chem., 2007, 17, 1695-1700.
77. Sharma, M.; Chaturvedi, V.; Manju, Y.K.; Bhatnagar, S.; Srivastava, K.; Puri, S.K.; Chauhan, P.M. Substituted quinolinyl chalcones and quinolinyl pyrimidines as a new class of anti-infective agents. Eur. J. Med. Chem., 2009, 44, 2081-2091.
78. Ajay, A.; Singh, V.; Singh, S.; Pandey, S.; Gunjan, S.; Dubey, D.; Sinha, S.K.; Singh, B.N.; Chaturvedi, V.; Tripathi, R.; Ramchandran, R.; Tripathi, R.P. Synthesis and bio-evaluation of alkylaminoaryl phenyl cyclopropyl methanones as antitubercular and antimalarial agents. Bioorg. Med. Chem., 2010, 18, 8289-8301.
79. Greenwood, B.; Mutabingwa, T. Malaria in 2002. Nature, 2002, 415, 670-672. (Pubitemid 34136399)
80. Li, R.; Kenyon, G.L.; Cohen, F.E.; Chen, X.; Gong, B.; Dominguez, J.N.; Davidson, E.; Kurzban, G.; Miller, R.E.; Nuzum, E.O.; Rosenthal, P.J.; McKerrow. J.H. In vitro antimalarial activity of chalcones and their derivatives. J. Med. Chem. 1995, 38, 5031-5037. (Pubitemid 26012258)
81. Wanare, G.; Aher, R.; Kawathekar, N.; Ranjan, R.; Kaushik, N.K.; Sahal, D. Synthesis of novel α-pyranochalcones and pyrazoline derivatives as Plasmodium falciparum growth inhibitors. Bioorg. Med. Chem. Lett., 2010, 20, 4675-4678.
82. Geyer, J.A.; Keenan, S.M.; Woodard, C.L.; Thompson, P.A.; Gerena, L.; Nichols, D.A.; Gutteridge, C.E.; Waters, N.C. Selective inhibition of Pfmrk, a Plasmodium falciparum CDK, by antimalarial 1,3-diaryl-2-propenones. Bioorg. Med. Chem. Lett., 2009, 19, 1982-1985.
83. Chen, M.; Theander, T.G.; Christensen, S.B.; Hviid, L.; Zhai, L.; Kharazmi, A. Lic A, a new antimalarial agent, inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection. Antimicrob. Agents Chemother., 1994, 38, 1470-1475. (Pubitemid 24203554)
84. Liu, M.; Wilairat, P.; Go, M.L. Antimalarial alkoxylated and hydroxylated chalcones: Structure activity relationship analysis. J. Med. Chem. 2001, 44, 4443-4452. (Pubitemid 33131668)
85. Dominguez, J.N.; Charris, J.E.; Lobo, G.; Domínguez, N.G.; Moreno, M.M.; Riggione, F.; Sanchez, E.; Olson, J.; Rosenthal, P.J. Synthesis of quinolinyl chalcones and evaluation of their antimalarial activity. Eur. J. Med. Chem., 2001, 36, 555-560. (Pubitemid 32781719)
86. Wu, X.; Wilairat, P.; Go, M. Antimalarial activity of ferrocenyl chalcone. Bioorg. Med. Chem. Lett., 2002, 12, 2299-2302.
87. Dominguez, J.N.; Leon, C.; Rodrigues, J.; Dominguez, N.G.; Gut, J.; Rosenthal, P.J. Synthesis and evaluation of new antimalarial phenylurenyl chalcone derivatives. J. Med. Chem., 2005, 48, 3654-3658. (Pubitemid 40664115)
88. Dominguez, J.N.; Leon, C.; Rodrigues, J.; Dominguez, N.G.; Gut, J.; Rosenthal, P.J. Synthesis and antimalarial activity of sulfonamide chalcone derivatives. Il Farmaco, 2005, 60, 307-311. (Pubitemid 40545945)
89. Gutteridge, C.E.; Nichols, D.A.; Curtis, S.M.; Thota, D.S.; Vo, J.V.; Gerena, L.; Montip, G.; Asher, C.O.; Diaz, D.S.; Ditusa, C.A.; Smith, K.S.; Bhattacharjee, A.K. In vitro and in vivo efficacy and in vitro metabolism of 1-phenyl-3-aryl-2-propen-1-ones against Plasmodium falciparum. Bioorg. Med. Chem. Lett., 2006, 16, 5682-5686. (Pubitemid 44415433)
90. Mishra, N.; Arora, P.; Kumar, B.; Mishra, L.C.; Bhattacharya, A.; Awasthi, S.K.; Bhasin, V.K. Synthesis of novel substituted 1,3-diaryl propenone derivatives and their antimalarial activity in vitro. Eur. J. Med. Chem., 2008, 43, 1530-1535. (Pubitemid 351885216)
91. Hans, R.H.; Guantai, E.M; Lategan, C.; Smith, P.J.; Wan, B.; Franzblau, S.G.; Gut, J.; Rosenthal, P.J.; Chibale, K. Synthesis, antimalarial and antitubercular activity of acetylenic chalcones. Bioorg. Med. Chem. Lett., 2010, 20, 942-944.
92. Kumar, R.; Mohanakrishnan, D.; Sharma, A.; Kaushik, N.K.; Kalia, K.; Sinha, A.K.; Sahal, D. Reinvestigation of structure-activity relationship of methoxylated chalcones as antimalarials: Synthesis and evaluation of 2,4,5-trimethoxy substituted patterns as lead candidates derived from abundantly available natural α-asarone. Eur. J. Med. Chem., 2010, 45, 5292-5301.
93. Tomar, V.; Bhattacharjee, G.; Kamaluddin, A.K.; Rajakumar, S.; Srivastava, K.; Puri, S.K. Synthesis of new chalcone derivatives containing acridinyl moiety with potential antimalarial activity. Eur. J. Med. Chem., 2010, 45, 745-751.
94. Guantai, E.M.; Ncokazi, K.; Egan, T.J.; Gut, J.; Rosenthal, P.J.; Smith, P.J.; Chibale, K. Design, synthesis and in vitro antimalarial evaluation of triazolelinked chalcone and dienone hybrid compounds. Bioorg. Med. Chem., 2010, 18, 8243-8256.
95. Hans, R.H.; Gut, J.; Rosenthal, P.J.; Chibale, K. Comparison of the antiplasmodial and falcipain-2 inhibitory activity of beta-amino alcohol thiolactone-chalcone and isatin-chalcone hybrids. Bioorg. Med. Chem. Lett., 2010, 20, 2234-2237.
96. Hayat, F.; Moseley, E.; Salahuddin, A.; Van Zyl, R.L.; Azam, A. Antiprotozoal activity of chloroquinoline based chalcones. Eur. J. Med. Chem., 2011, 46, 1897-1905.
97. Kayser, O.; Kiderlen, A.F. In vitro leishmanicidal activity of naturally occurring chalcones. Phytother. Res., 2001, 15, 148-152.
98. Chen, M.; Christensen, S.B.; Blom, J.; Lemmich, E.; Nadelmann, L.; Fich, K. Lic A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania. Antimicrob. Agents Chemother., 1993, 37, 2550-2556. (Pubitemid 23357845)
99. Nielsen, S.F.; Chen, M.; Theander, T.G.; Kharazmi, A.; Christensen, S.B. Synthesis of antiparasitic licorice chalcones. Bioorg. Med. Chem. Lett., 1995, 5, 449-452.
100. Liu, M.; Wilairat, P.; Croft, S.L.; Tan, A.L.C.; Go, M.L. Structure-activity relationships of antileishmanial and antimalarial chalcones. Bioorg. Med. Chem., 2003, 11, 2729-2738. (Pubitemid 36682997)
101. Narender, T.; Khaliq, T.; Shweta, Goyal, N.N.; Gupta, S. Synthesis of chromenochalcones and evaluation of their in vitro antileishmanial activity. Bioorg. Med. Chem., 2005, 13, 6543-6550. (Pubitemid 41539318)
102. Andrighetti-Fröhner, C.R.; Oliveira, K.N.; Gaspar-Silva, D.; Pacheco, L.K.; Joussef, A.C.; Steindel, M.; Sim~oes, C.M.O.; Souza, A.M.T.; Magalhaes, U.O.; Afonso, I.F., Rodrigues, C.R.; Nunes, R.J.; Castro, H.C. Synthesis, biological evaluation and SAR of sulfonamide 4-methoxychalcone derivatives with potential antileishmanial activity. Eur. J. Med. Chem., 2009, 44, 755-763.
103. Nazarian, Z.; Emami, S.; Heydari, S.; Ardestani, S.K.; Nakhjiri, M.; Poorrajab, F.; Shafiee, A.; Foroumadi, A. Novel antileishmanial chalconoids: Synthesis and biological activity of 1-or 3-(6-chloro-2H-chromen-3-yl)propen-1- ones. Eur. J. Med. Chem., 2010, 45, 1424-1429.
104. Enoki, T.; Ohnogi, H.; Nagamine, K.; Kudo, Y.; Sugiyama, K.; Tanabe, M.; Kobayashi, E.; Sagawa, H.; Gato, I. Antidiabetic activities of chalcones isolated from a Japanese herb, Angelica keiskei. J. Agric. Food Chem., 2007, 55, 6013-6017. (Pubitemid 47235652)
105. Seo, W.D.; Kim, J.H.; Kang, J.E.; Ryu, H.W., Curtis-Long, M.J., Lee, H.S., Yang, M.S., Park, K.H. Sulfonamide chalcone as a new class of α-glucosidase inhibitors. Bioorg. Med. Chem. Lett., 2005, 15, 5514-5516. (Pubitemid 41562981)
106. Alberton, E.H.; Damazio, R.G.; Cazarolli, L.H.; Chiaradia, L.D.; Leal, P.C.; Nunes, R.J.; Yunes, R.A.; Silva, F.R.M.B. Influence of chalcone analogues on serum glucose levels in hyperglycemic rats. Chem. Biol. Interact., 2008, 171, 355-362.
107. Damazio, R.G.; Zanatta, A.P.; Cazarolli, L.H.; Chiaradia, L.D.; Mascarello, A.; Nunes, R.J.; Yunes, R.A.; Silva, F.R.M.B. Antihyperglycemic activity of naphthylchalcones. Eur. J. Med. Chem., 2010, 45, 1332-1337.
108. Seo, S.Y.; Sharma, V.K.; Sharma, N.; Mushroom tyrosinase: Recent prospects. J. Agric. Food Chem., 2003, 51, 2837-2853.
109. Nerya, O.; Vaya, J.; Musa, R.; Izrael, S.; Ben-Arie, R.; TAMIR, S. Glabrene and isoliquiritigenin as tyrosinase inhibitors from licorice roots. J. Agric. Food Chem., 2003, 51, 1201-1207.
110. Khatib, S.; Nerya, O.; Musa, R.; Shmuel, M.; Tamir, S.; Vaya, J. Chalcones as potent tyrosinase inhibitors: The importance of a 2,4-substituted resorcinol moiety. Bioorg. Med. Chem., 2005, 13, 433-441. (Pubitemid 39642925)
111. Jun, N.; Hong G.; Jun, K. Synthesis and evaluation of 2', 4', 6'-trihydroxychalcones as a new class of tyrosinase inhibitors. Bioorg. Med. Chem., 2007, 15, 2396-2402. (Pubitemid 46240911)
112. Seo, W.D.; Ryu, Y.B.; Curtis-Long, M.J.; Lee, C.W.; Ryu, H.W.; Jang, K.C.; Park, K.H. Evaluation of anti-pigmentary effect of synthetic sulfonylamino chalcone. Eur. J. Med. Chem., 2010, 45, 2010-2017.
113. Barfod, L.; Kemp, K.; Hansen, M.; Kharazmi, A. Chalcones from Chinese liquorice inhibit proliferation of T cells and production of cytokines. Int. Immunopharmacol., 2002, 2, 545-555. (Pubitemid 34169749)
114. Fontenele, J.B.; Leal, L.K.A.M.; Ferreira, M.A.D.; Silveira, E.R.; Viana, G.S.B. Antiplatelet effect of lonchocarpin and derricin isolated from Lonchocarpus sericeus. Pharm. Biol., 2005, 43, 726-731. (Pubitemid 43062372)
115. Dong, X.; Du, L.; Pan, Z.; Liu, T.; Yang, B.; Hu, Y. Synthesis and biological evaluation of novel hybrid chalcone derivatives as vasorelaxant agents. Eur. J. Med. Chem., 2010, 45, 3986-3992.